GSK3B and Alzheimer disease: Nonetheless, downregulation of GSK-3β levels and modulation of the Wnt pathway are reported to be protective in many neurodegenerative diseases, including AD (Toledo and Inestrosa, 2010), which adds value to our study by using sesamol.